Skip to content
Events

Details

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
7 Nov. 2019
3:00 PM
Location
North America
Affiliation
Illumina, Inc.
Presenter
Phil Febbo
Topic
Oncology, Cancer research
Watch Now

Related Events

Nov 4
Illumina Innovation Days
Nov 4, 2025 – Dec 5, 2025
Join us as we discuss new innovative technology offerings from the Illumina product pipeline and introduce our newest system – the MiSeq i100 Series.
View Event
Nov 11
AMP 2025 Annual Meeting and Expo
Nov 11, 2025 – Nov 15, 2025
Visit Illumina booth 719 at AMP to explore streamlined workflows and innovative sequencing solutions.
View Event
Dec 3
Unlocking the power of Comprehensive Genomic Profiling: From Evidence to Practice
Dec 3, 2025
Comprehensive Genomic Profiling (CGP) is reshaping precision oncology by using next-generation sequencing (NGS) to assess hundreds of cancer-related genes and biomarkers in a single assay. While CGP offers deeper biological insights and more personalised treatment strategies, its clinical impact hinges on rigorous assay validation and thoughtful implementation. Join us to learn how robust validation, regional data, and collaborative approaches can unlock the full potential of CGP in clinical oncology.
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see sapac.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.